Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
E-pub ahead of print

Response to AASLD editorial/message from the president

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Viral persistence, liver disease and host response in Hepatitis C-like virus rat model

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Plasma Cystatin C is a predictor of renal dysfunction, ACLF and mortality in patients with acutely decompensated liver cirrhosis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. The Royal Free Hospital Cirrhosis Glomerular Filtration Rate: Validation in a Danish Cohort

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Assessment of systolic function in the evaluation of patients with cirrhosis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Rifaximin has no effect on hemodynamics in decompensated cirrhosis - A randomized, double blind, placebo controlled trial

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Acupuncture for chronic hepatitis B (Protokol)

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  2. Interventions for altering blood pressure in people with acute subarachnoid haemorrhage (Protocol)

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  3. Radix Sophorae flavescentis for chronic hepatitis B (Protocol)

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  4. Radix Sophorae flavescentis versus antiviral drugs for chronic hepatitis B (Protocol)

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

Vis graf over relationer

A commentary [1] criticized our systematic review regarding the use of direct-acting agents (DAAs) in chronic hepatitis C [2]. The following represents our major disagreements. Sustained virological response (SVR) is a non-validated surrogate outcome. The principles of evidence-based medicine require that it be validated in randomized clinical trials (RCTs) by showing parallel benefits in clinical outcomes [3]. This article is protected by copyright. All rights reserved.

OriginalsprogEngelsk
TidsskriftHepatology (Baltimore, Md.)
ISSN0270-9139
DOI
StatusE-pub ahead of print - 1 okt. 2018

ID: 55428635